|
|
|
Year ended December 31, |
||||
|
|
|
2015 |
|
2016 |
|
2017 |
|
|
|
(in thousands) |
||||
|
Expenses arising from share-based payment grants settled by the Company’s equity instruments |
|
6,471 |
|
4,801 |
|
5,225 |